Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4

Section 1

Interpretation

Cite as Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, s. 1 · current to November 11, 2026 · consolidated from January 1, 2026 · read from e-Laws on November 17, 2026

The text

(1) In this Act, “Accreditation Committee” means the Accreditation Committee of the College; (“comité d’agrément”) “by-laws” means the by-laws made under this Act; (“règlements administratifs”) “cannabis” has the same meaning as in subsection 2 (1) of the Cannabis Act (Canada); (“cannabis”) “certificate of accreditation” means a certificate of accreditation issued by the Registrar of the College under subsection 139 (2); (“certificat d’agrément”) “certificate of authorization” has the same meaning as in the Regulated Health Professions Act, 1991; (“certificat d’autorisation”) “certificate of registration” means a certificate of registration within the meaning of the Health Professions Procedural Code issued by the Registrar of the College; (“certificat d’inscription”) “chiropodist” means a member of the College of Chiropodists of Ontario or another person prescribed by the regulations; (“podologue”) “College” means the Ontario College of Pharmacists; (“Ordre”) “Council” means the Council of the College; (“conseil”) “dental hygienist” means a member of the College of Dental Hygienists of Ontario or another person prescribed by the regulations; (“hygiéniste dentaire”) “designated manager” means the pharmacist designated by the owner of the pharmacy, in information provided to the College, as the pharmacist responsible for managing the pharmacy; (“gérant désigné”) “Discipline Committee” means the Discipline Committee of the College; (“comité de discipline”) “drug” means any substance or preparation containing any substance, (a) manufactured, sold or represented for use in, (i) the diagnosis, treatment, mitigation or prevention of a disease, disorder, abnormal physical or mental state or the symptoms thereof, in humans, animals or fowl, or (ii) restoring, correcting or modifying functions in humans, animals or fowl, (b) referred to in Schedule I, II or III, (c) listed in a publication named by the regulations, or (d) named in the regulations, but does not include, (e) any substance or preparation referred to in clause (a), (b), (c) or (d) manufactured, offered for sale or sold as, or as part of, a food, drink or cosmetic, (f) any “natural health product” as defined from time to time by the Natural Health Products Regulations under the Food and Drugs Act (Canada), unless the product is a substance that is identified in the regulations as being a drug for the purposes of this Act despite this clause, either specifically or by its membership in a class or its listing or identification in a publication, (f.1) cannabis, other than, (i) a drug containing cannabis to which the Cannabis Regulations (Canada) apply, (ii) cannabis obtained for medical purposes in accordance with Part 14 of those Regulations or in accordance with a court order, and (iii) cannabis that is identified in the regulations as being a drug for the purposes of this Act despite this clause, (g) a substance or preparation named in Schedule U, (h) a substance or preparation listed in a publication named by the regulations, or (i) a substance or preparation that the regulations provide is not a drug; (“médicament”) “health profession corporation” has the same meaning as in the Regulated Health Professions Act, 1991; (“société professionnelle de la santé”) “Health Professions Procedural Code” means the Health Professions Procedural Code set out in Schedule 2 to the Regulated Health Professions Act, 1991; (“Code des professions de la santé”) “hospital” means a hospital within the meaning of the Public Hospitals Act or a private hospital within the meaning of the Private Hospitals Act; (“hôpital”) “hospital patient” means a patient within the meaning of the Public Hospitals Act or the Private Hospitals Act; (“malade d’un hôpital”) “hospital pharmacy” means a location that is deemed to be a pharmacy by virtue of section 119; (“pharmacie en milieu hospitalier”) “institutional pharmacy” means a premises that is deemed to be a pharmacy by virtue of section 120; (“pharmacie en milieu institutionnel”) “intern” means a member of the College who holds a certificate of registration as an intern under the Pharmacy Act, 1991; (“interne”) “intern technician” means a member of the College who holds a certificate of registration as an intern technician under the Pharmacy Act, 1991; (“technicien stagiaire”) “member” means a member of the College; (“membre”) “midwife” means a member of the College of Midwives of Ontario or another person prescribed by the regulations; (“sage-femme”) “Minister” means the Minister of Health or such other member of the Executive Council as may be assigned the administration of this Act under the Executive Council Act; (“ministre”) “optometrist” means a member of the College of Optometrists of Ontario or another person prescribed by the regulations; (“optométriste”) “pharmacist” means a member of the College who holds a certificate of registration as a pharmacist under the Pharmacy Act, 1991 or another person prescribed by the regulations; (“pharmacien”) “pharmacy” means a premises in or in part of which prescriptions are compounded or dispensed for the public or drugs are sold by retail, and includes a remote dispensing location; (“pharmacie”) “pharmacy technician” means a member of the College who holds a certificate of registration as a pharmacy technician under the Pharmacy Act, 1991 or another person prescribed by the regulations; (“technicien en pharmacie”) “prescriber” means a person who is authorized under the laws of a province or territory of Canada to give a prescription within the scope of his or her practice of a health discipline; (“personne autorisée à prescrire des médicaments”) “prescription” means a direction from a prescriber directing the dispensing of any drug or mixture of drugs for a designated person or animal; (“ordonnance”) “proprietary misconduct” means proprietary misconduct as defined in the regulations; (“faute liée à la spécialité”) “Registrar” means the Registrar of the College; (“registrateur”) “regulations” means the regulations made under this Act; (“règlements”) “remote dispensing location” has the meaning provided for in the regulations. (“téléofficine”) 2007, c. 10, Sched. L, s. 1 (1, 2); 2009, c. 26, s. 8 (1, 2); 2014, c. 14, Sched. 2, s. 1; 2017, c. 11, Sched. 1, s. 1; 2018, c. 12, Sched. 1, s. 21 (1, 2); 2025, c. 11, Sched. 3, s. 1. (2) A reference in this Act to Schedule I, II, III or U is a reference to such Schedule established by the regulations. 2007, c. 10, Sched. L, s. 1 (3). (2.1) A reference in any other Act or regulation to a term as defined in subsection 117 (1) of this Act shall be deemed to be a reference to the same term as defined in subsection (1) of this section. 2007, c. 10, Sched. L, s. 1 (1). (3) Nothing in this Act shall be construed to require a hearing to be held within the meaning of the Statutory Powers Procedure Act unless the holding of a hearing is specifically referred to. R.S.O. 1990, c. H.4, s. 1 (3).
Read the Drug and Pharmacies Regulation Act on e-Laws ↗